These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 9689133)

  • 21. The function of the microtubule-associated protein tau is variably modulated by graded changes in glycogen synthase kinase-3beta activity.
    Leroy K; Menu R; Conreur JL; Dayanandan R; Lovestone S; Anderton BH; Brion JP
    FEBS Lett; 2000 Jan; 465(1):34-8. PubMed ID: 10620702
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Downregulation of glycogen synthase kinase-3beta (GSK-3beta) protein expression during neuroblastoma IMR-32 cell differentiation.
    Muñoz-Montaño JR; Moreno FJ; Avila J; Díaz-Nido J
    J Neurosci Res; 1999 Feb; 55(3):278-85. PubMed ID: 10348658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phosphorylation of tau protein by recombinant GSK-3beta: pronounced phosphorylation at select Ser/Thr-Pro motifs but no phosphorylation at Ser262 in the repeat domain.
    Godemann R; Biernat J; Mandelkow E; Mandelkow EM
    FEBS Lett; 1999 Jul; 454(1-2):157-64. PubMed ID: 10413115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glycogen synthase kinase-3beta is complexed with tau protein in brain microtubules.
    Sun W; Qureshi HY; Cafferty PW; Sobue K; Agarwal-Mawal A; Neufield KD; Paudel HK
    J Biol Chem; 2002 Apr; 277(14):11933-40. PubMed ID: 11812770
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PS1 activates PI3K thus inhibiting GSK-3 activity and tau overphosphorylation: effects of FAD mutations.
    Baki L; Shioi J; Wen P; Shao Z; Schwarzman A; Gama-Sosa M; Neve R; Robakis NK
    EMBO J; 2004 Jul; 23(13):2586-96. PubMed ID: 15192701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sequential phosphorylation of Tau by glycogen synthase kinase-3beta and protein kinase A at Thr212 and Ser214 generates the Alzheimer-specific epitope of antibody AT100 and requires a paired-helical-filament-like conformation.
    Zheng-Fischhöfer Q; Biernat J; Mandelkow EM; Illenberger S; Godemann R; Mandelkow E
    Eur J Biochem; 1998 Mar; 252(3):542-52. PubMed ID: 9546672
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isoorientin, a GSK-3β inhibitor, rescues synaptic dysfunction, spatial memory deficits and attenuates pathological progression in APP/PS1 model mice.
    Tan X; Liang Z; Li Y; Zhi Y; Yi L; Bai S; Forest KH; Nichols RA; Dong Y; Li QX
    Behav Brain Res; 2021 Feb; 398():112968. PubMed ID: 33069740
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Indirubins inhibit glycogen synthase kinase-3 beta and CDK5/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors?
    Leclerc S; Garnier M; Hoessel R; Marko D; Bibb JA; Snyder GL; Greengard P; Biernat J; Wu YZ; Mandelkow EM; Eisenbrand G; Meijer L
    J Biol Chem; 2001 Jan; 276(1):251-60. PubMed ID: 11013232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Curcumin mediates presenilin-1 activity to reduce β-amyloid production in a model of Alzheimer's Disease.
    Xiong Z; Hongmei Z; Lu S; Yu L
    Pharmacol Rep; 2011; 63(5):1101-8. PubMed ID: 22180352
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Presenilin deficiency enhances tau phosphorylation and its secretion.
    Sun Y; Islam S; Gao Y; Nakamura T; Tomita T; Michikawa M; Zou K
    J Neurochem; 2024 Sep; 168(9):2956-2973. PubMed ID: 38946496
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Involvement of glycogen synthase kinase-3beta and tau phosphorylation in neuronal Golgi disassembly.
    Elyaman W; Yardin C; Hugon J
    J Neurochem; 2002 May; 81(4):870-80. PubMed ID: 12065646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. tau kinases in the rat heat shock model: possible implications for Alzheimer disease.
    Shanavas A; Papasozomenos SC
    Proc Natl Acad Sci U S A; 2000 Dec; 97(26):14139-44. PubMed ID: 11121021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glycogen synthase kinase-3beta phosphorylates protein tau and rescues the axonopathy in the central nervous system of human four-repeat tau transgenic mice.
    Spittaels K; Van den Haute C; Van Dorpe J; Geerts H; Mercken M; Bruynseels K; Lasrado R; Vandezande K; Laenen I; Boon T; Van Lint J; Vandenheede J; Moechars D; Loos R; Van Leuven F
    J Biol Chem; 2000 Dec; 275(52):41340-9. PubMed ID: 11007782
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The pathogenic L392V mutation of presenilin 1 decreases the affinity to glycogen synthase kinase-3 beta.
    Gantier R; Gilbert D; Dumanchin C; Campion D; Davoust D; Toma F; Frébourg T
    Neurosci Lett; 2000 Apr; 283(3):217-20. PubMed ID: 10754226
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro phosphorylation of the cytoplasmic domain of the amyloid precursor protein by glycogen synthase kinase-3beta.
    Aplin AE; Gibb GM; Jacobsen JS; Gallo JM; Anderton BH
    J Neurochem; 1996 Aug; 67(2):699-707. PubMed ID: 8764598
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transient increases in intracellular calcium result in prolonged site-selective increases in Tau phosphorylation through a glycogen synthase kinase 3beta-dependent pathway.
    Hartigan JA; Johnson GV
    J Biol Chem; 1999 Jul; 274(30):21395-401. PubMed ID: 10409701
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lithium inhibits neurite growth and tau protein kinase I/glycogen synthase kinase-3beta-dependent phosphorylation of juvenile tau in cultured hippocampal neurons.
    Takahashi M; Yasutake K; Tomizawa K
    J Neurochem; 1999 Nov; 73(5):2073-83. PubMed ID: 10537067
    [TBL] [Abstract][Full Text] [Related]  

  • 38. L-3-n-butylphthalide reduces tau phosphorylation and improves cognitive deficits in AβPP/PS1-Alzheimer's transgenic mice.
    Peng Y; Hu Y; Xu S; Li P; Li J; Lu L; Yang H; Feng N; Wang L; Wang X
    J Alzheimers Dis; 2012; 29(2):379-91. PubMed ID: 22233765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular cloning and characterization of the human glycogen synthase kinase-3beta promoter.
    Lau KF; Miller CC; Anderton BH; Shaw PC
    Genomics; 1999 Sep; 60(2):121-8. PubMed ID: 10486203
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Leucine-rich repeat kinase 2 regulates tau phosphorylation through direct activation of glycogen synthase kinase-3β.
    Kawakami F; Shimada N; Ohta E; Kagiya G; Kawashima R; Maekawa T; Maruyama H; Ichikawa T
    FEBS J; 2014 Jan; 281(1):3-13. PubMed ID: 24165324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.